Literature DB >> 11819247

Partial isolation and identification of hepatic stimulator substance mRNA extracted from human fetal liver.

Xiao-Ming Yang, Ling Xie, Gui-Chun Xing, Zu-Ze Wu, Fu-Chu He.   

Abstract

AIM:To partially isolate and identify hepatic stimulator substance mRNA from human fetal liver tissues.
METHODS: The poly (A)mRNA was extracted from human fetal liver tissues of 4-5 month gestation, fractionated by size on sucrose gradient centrifugation, translated into protein from each fraction in vitro and then its products were tested for HSS activity.
RESULTS: Twenty-two 500 total RNA was obtained from human fetal liver tissues and pooled.mRNA of 420 was yielded,processed by oligo(dT)-cellulose column chromatography, then was size-fractionated by ultracentrifution on a continuous sucrose density gradient (5%-25%), and separated into 18 fractions.Translated products of mRNA in fraction 8 and 9 could produce a two-fold increase in the incorporation of( 3)H-TdR into DNA of SMMC-7721 hepatoma cells and in a heat resistant and organ-specific way.
CONCLUSION: The partially purified HSS mRNA was obtained and this would facilitate the cloning of HSS using expression vectors.

Entities:  

Year:  1998        PMID: 11819247      PMCID: PMC4688625          DOI: 10.3748/wjg.v4.i2.100

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

Review 1.  Hepatic stimulator substance. Discovery, characteristics and mechanism of action.

Authors:  D R LaBrecque
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells.

Authors:  Z Q Yao; W S Yang; W B Zhang; Y N Chen; F Y Yang
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

4.  Stimulation of HTC hepatoma cell growth in vitro by hepatic stimulator substance (HSS). Interactions with serum, insulin, glucagon, epidermal growth factor and platelet derived growth factor.

Authors:  D R Labrecque; M Wilson; S Fogerty
Journal:  Exp Cell Res       Date:  1984-02       Impact factor: 3.905

5.  Synthesis of full length cDNAs from four partially purified oviduct mRNAs.

Authors:  G N Buell; M P Wickens; F Payvar; R T Schimke
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

6.  Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.

Authors:  D R LaBrecque; L A Pesch
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

7.  Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue.

Authors:  F He; C Wu; Q Tu; G Xing
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

  7 in total
  2 in total

1.  Identification and characterization of a novel isoform of hepatopoietin.

Authors:  Jun Lu; Wang-Xiang Xu; Yi-Qun Zhan; Xiao-Lin Cui; Wei-Min Cai; Fu-Chu He; Xiao-Ming Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  TECA hybrid artificial liver support system in treatment of acute liver failure.

Authors:  Y L Xue; S F Zhao; Y Luo; X J Li; Z P Duan; X P Chen; W G Li; X Q Huang; Y L Li; X Cui; D G Zhong; Z Y Zhang; Z Q Huang
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.